Increase in force of contraction by activation of the Na+‘ox/Ca2+‘ox‐exchangerin human myocardium

Authors:

Abstract
Aims The aim of the present study was to investigate whether agents which enhance force of contraction via increasing intracellular Na+, i.e. cAMP‐independently, remain effective in failing human myocardium. Methods Cumulative concentration‐response curves with (±)BDF 9148 (0.01–10 μmol l−1 ), a Na+‐channel activator, and ouabain (0.01–0.1 μmol l−1 ), a Na+/K+‐ATPase inhibitor, were performed on electrically driven left ventricular human papillary muscle strips (1 Hz, 37° C; dilative cardiomyopathy, NYHA IV, heart transplantation, n=16; nonfailing, donor hearts, n=5). The β‐adrenoceptor agonist isoprenaline (0.001–1 μmol l−1 ) and Ca2+ (1.8–15 mmol l−1 ) were studied for control. In addition, Ca2+ response curves were obtained on skinned fibre preparations from left ventricular myocardium (NYHA IV, n=7) in the presence of BDF 9148 (1 μmol l−1 ) or a high Na+ concentration (50 mmol l−1 ) to investigate a possible direct or indirect interaction of (±)BDF 9148 with the myofilaments. Results While isoprenaline was significantly less effective in increasing force of contraction in failing human myocardium than in nonfailing myocardium (P2+. However, the potency for (±)BDF 9148 to increase force of contraction was higher in NYHA IV than in nonfailing human myocardium (P−1 ) nor an increased concentration of Na+ (50 mmol l−1 ) altered the Ca2+ sensitivity or maximal developed tension of the contractile apparatus in experiments on chemically skinned left ventricular fibres. Conclusions The enhanced sensitivity of the failing human myocardium towards Na+‐channel modulation is not due to a direct or indirect interaction of (±)BDF 9148 with cardiac myofilaments but may be due to an altered Na+‐homeostasis in human heart failure.